A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and Staging of Pancreatic Ductal Adenocarcinoma.

Zijian YangMichael J LaRiviereJina KoJacob E TillTheresa ChristensenStephanie S YeeTaylor A BlackKyle TienAndrew LinHanfei ShenNeha BhagwatDaniel HermanAndrew AdallahMark H O'HaraCharles M VollmerBryson W KatonaBen Z StangerDavid IssadoreErica L Carpenter

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)

Algorithmically combining blood-based biomarkers may improve PDAC diagnostic accuracy and preoperative identification of nonmetastatic patients best suited for surgery, although larger validation studies are necessary.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
minimally invasive
patients undergoing
coronary artery bypass
coronary artery disease
acute coronary syndrome
percutaneous coronary intervention
patient reported
case control